Plasma p-tau biomarkers, particularly p-tau217, are known to associate with Aβ and tau pathologies and predict cognitive decline, while plasma GFAP associates with Aβ pathology, and neurofilament light with neuronal injury. The gene discussed is GFAP; the disease is Mental deterioration.